125 related articles for article (PubMed ID: 3002265)
21. Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
Darby G; Churcher MJ; Larder BA
J Virol; 1984 Jun; 50(3):838-46. PubMed ID: 6328014
[TBL] [Abstract][Full Text] [Related]
22. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
Harmenberg J; Källander CF; Gronowitz JS
Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
[TBL] [Abstract][Full Text] [Related]
23. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Fyfe JA; McKee SA; Keller PM
Mol Pharmacol; 1983 Sep; 24(2):316-23. PubMed ID: 6310366
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wilber BA; Docherty JJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide.
Graham D; Larder BA; Inglis MM
J Gen Virol; 1986 Apr; 67 ( Pt 4)():753-8. PubMed ID: 3007662
[TBL] [Abstract][Full Text] [Related]
27. Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.
Ayisi NK; De Clercq E; Wall RA; Hughes H; Sacks SL
Antimicrob Agents Chemother; 1984 Nov; 26(5):762-5. PubMed ID: 6097176
[TBL] [Abstract][Full Text] [Related]
28. Thymidine kinase activity of biochemically transformed mouse cells after superinfection by thymidine kinase-negative, temperature-sensitive, herpes simplex virus mutants.
Kit S; Dubbs DR; Schaffer PA
Virology; 1978 Apr; 85(2):456-63. PubMed ID: 208236
[No Abstract] [Full Text] [Related]
29. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
[TBL] [Abstract][Full Text] [Related]
30. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
[No Abstract] [Full Text] [Related]
31. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
[TBL] [Abstract][Full Text] [Related]
32. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
Campione-Piccardo J; Rawls WE
Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
[TBL] [Abstract][Full Text] [Related]
33. Induction of nuclear deoxyribopyrimidine triphosphatase and sensitivity of clinical isolates of herpes simplex virus to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wohlrab F; Mayo DR; Hsiung GD; Francke B
Antiviral Res; 1983 Mar; 3(1):1-5. PubMed ID: 6135391
[TBL] [Abstract][Full Text] [Related]
34. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
[TBL] [Abstract][Full Text] [Related]
35. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
[TBL] [Abstract][Full Text] [Related]
36. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Shigeta S; Yokota T; De Clercq E
Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264
[No Abstract] [Full Text] [Related]
37. The effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on DNA repair and mutagenesis of herpes simplex virus type 1.
Bubley GJ; Balzarini J; Crumpacker CS; de Clercq E; Schnipper LE
Virology; 1987 Nov; 161(1):242-4. PubMed ID: 2823464
[TBL] [Abstract][Full Text] [Related]
38. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
Swierkosz EM; Arens MQ; Rivetna KA
J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
[TBL] [Abstract][Full Text] [Related]
39. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of three methods for typing herpes simplex virus.
Salmerón F; Pérez Breña P; Rojas JM; Hernáez Lobo R; Tabarés E
Eur J Clin Microbiol; 1987 Dec; 6(6):664-7. PubMed ID: 2831045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
